REFERENCES
- Aungst, B. J., Blake, J. A., and Hussain, M. A. 1990. Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res. 7:712–718.
- Bhatia, K. S., and Singh, J. 1998. Synergistic effect of iontophoresis and a series of fatty acids on LHRH permeability through porcine skin. J. Pharm. Sci. 87:462–469.
- Engblom, J., Engstrom, S., and Jonsson, B. 1998. Phase coexistence in cholesterol-fatty acid mixtures and the effect of the penetration enhancer Azone. J. Control. Rel. 52:271–280.
- Francoeur, M. L., Golden, G. M., and Potts, R. O. 1990. Oleic acid: Its effects on stratum corneum in relation to (trans)dermal drug delivery. Pharm. Res. 7:621–627.
- Hatanaka, T., Inuma, M., Sugibayashi, K., and Morimoto, Y. 1990. Prediction of skin permeability of drugs. I. Comparison with artificial membrane. Chem. Pharm. Bull. 38:3452–3459.
- Inagi, T., and Terada, H. 1983. Effects of nonsteroidal antiinflammatory drugs on the proton exchange reaction between octanol and water: Its correlation with their inhibitions of inflammation and prostaglandin synthesis. Biochem. Biophys. Res. Commun. 113:745–750.
- Larrucea, E., Arellano, A., Santoyo, S., and Ygartua, P. 2001. Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin. Eur. J. Pharm. Biopharm. 52:113–119.
- Lee, C. K., Uchida, T., Kitagawa, K., Yagi, A., Kim, N. S., and Goto, S. 1994. Relationship between lipophilicity and skin permeability of various drugs from an ethanol/water/lauric acid system. Biol. Pharm. Bull. 17:1421–1424.
- Morimoto, K., Haruta, T., Tojima, H., and Takeuchi, Y. 1995. Enhancing mech- anisms of saturated fatty acids on the permeations of indomethacin and 6-carboxyfluorescein through rat skins. Drug Dev. Ind. Pharm. 21:1999– 2012.
- Morimoto, K., Tojima, H., Haruta, T., Suzuki, M., and Kakemi, M. 1996. Enhanc- ing effects of unsaturated fatty acids with various structures on the permeation of indomethacin through rat skin. J. Pharm. Pharmacol. 48:1133–1137.
- Oshima, T., Yoshikawa, H., Takada, K., and Muranishi, S. 1984. Enhancing effect of absorption promoters on percutaneous absorption of a model dye (6-carboxyfluorescein) as poorly absorbable drugs. I. Comparison of plasma levels after addition of various absorption promoters in rat. J. Pharmacobio- Dyn. 7:648–655.
- Potts, R. O., and Guy, R. H. 1995. A predictive algorithm for skin permeabil- ity: The effects of molecular size and hydrogen bond activity. Pharm. Res. 12:1628–1633.
- Shin, S. C., Shin, E. Y., and Cho, C. W. 2000. Enhancing effects of fatty acids on piroxicam permeation through rat skins. Drug Dev. Ind. Pharm. 26:563–566.
- Sinha, V. R., and Kaur, M. P. 2000. Permeation enhancers for transdermal drug delivery. Drug Dev. Ind. Pharm. 26:1131–1140.
- Smith, S. W., and Anderson,. B. D. 1995. Human skin permeability enhancement by lauric acid under equilibrium aqueous conditions. J. Pharm. Sci. 84:551– 556.
- Sugibayashi, K., Nakayama, S., Sek, T., Hosoya, K., and Morimoto, Y. 1992. Mechanism of skin penetration-enhancing effect by laurocapram. J. Pharm. Sci. 81:58–64.
- Walters, K. A. 2002. Dermatological and Transdermal Formulations. New York: Marcel Dekker.
- Yaginuma, H., Nakata, T., Toya, N., Murakami, T., Yamazaki, M., and Kamada, A. 1981. Rectal delivery of antiinflammatory drugs. I. The influence of an- tiinflammatory drugs on rectal absorption of beta-lactam antibiotics. Chem. Pharm. Bull. 29:2974–2985.